This question targets the NCLEX-RN Client Need category: Physiological Integrity, Reduction of Risk Potential. The scenario presents a young female with classic symptoms of a reproductive tract infection. The core of the question is to differentiate the specific clinical sign that is a hallmark diagnostic criterion for pelvic inflammatory disease (PID) from findings associated with other gynecological infections. PID is an ascending infection of the upper female genital tract, including the uterus, fallopian tubes, and ovaries, most commonly caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and increasingly recognized, Mycoplasma genitalium [1,2]. Understanding the clinical diagnostic criteria is critical because prompt empiric antibiotic therapy is necessary to prevent serious long-term sequelae such as chronic pelvic pain, ectopic pregnancy, and tubo-ovarian abscess (TOA) [2,3].
Cervical motion tenderness (CMT) during a bimanual examination is the finding most indicative of PID. CMT, along with uterine and adnexal tenderness, forms the minimum clinical diagnostic criteria for PID as established by the Centers for Disease Control and Prevention (CDC). The pathophysiology involves inflammation of the upper genital tract. When the cervix is manipulated during the bimanual exam, it stretches the inflamed peritoneum and pelvic structures, eliciting significant pain. This sign directly reflects the ascending nature of the infection from the lower genital tract to the upper pelvic organs, a hallmark of PID [2]. A tubo-ovarian abscess, a severe complication of PID, can develop from this localized infectious and inflammatory process, making early recognition of signs like CMT vital [2,3].
The other findings are more characteristic of different, often uncomplicated, lower genital tract infections rather than the upper tract involvement seen in PID.
For the NCLEX-RN, a question like this tests your ability to triage assessment findings and recognize a clinical emergency. When a patient presents with pelvic pain and discharge, your focused assessment must include a bimanual examination to check for CMT, uterine, or adnexal tenderness. The presence of any one of these findings in a sexually active young woman with no other identifiable cause of illness is sufficient to make a presumptive diagnosis of PID and initiate empiric treatment [2]. Delaying treatment can lead to severe complications, including TOA, which may present with a pelvic mass and, in rare cases, can rupture or cause bacteremia and septicemia [3]. The diagnosis is primarily clinical, supported by laboratory testing for Chlamydia trachomatis and Neisseria gonorrhoeae, and imaging such as transvaginal ultrasound if a TOA is suspected [2,3]. A systematic review and meta-analysis confirms the significant association between Mycoplasma genitalium and PID, highlighting the evolving understanding of the polymicrobial etiology of this disease [1].
Scenario: A 24-year-old female presents with lower abdominal pain and purulent vaginal discharge. She reports new onset of deep dyspareunia. Her last menstrual period was 2 weeks ago, and she has an intrauterine device (IUD) placed 6 months ago. Vital signs are within normal limits except for a temperature of 100.4 F (38 C).
Monitor closely for signs of a tubo-ovarian abscess (TOA) or peritonitis, which require hospitalization. Instruct the patient to return immediately for severe or worsening pain, persistent vomiting, high fever (>101 F/38.3 C), or failure to improve on oral antibiotics. A pelvic ultrasound or CT scan is indicated if TOA is suspected.
학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.